Danone’s CMO on adapting advertising as GLP-1 upends the food industry

In This Article:

This story was originally published on Marketing Dive. To receive daily news and insights, subscribe to our free daily Marketing Dive newsletter.

The market for GLP-1 medication is estimated by several forecasters to bring in over $100 billion in annual revenue within the next decade. But the drug category, initially developed for diabetes but now widely used for weight loss, has also begun to affect the food and beverage industry as consumers on GLP-1 medication — about one in eight U.S. adults — require protein-rich, nutrient-dense diets.

For Danone, the marketer of brands including Oikos Greek Yogurt and dairy substitute Silk, manufacturing the product mix needed by consumers on GLP-1 medication is one thing — communicating to meet this changing consumer base is another, especially with the food industry at a “tipping point,” said Danone North America CMO Linda Bethea.

Danone NA CMO Linda Bethea
Danone NA CMO Linda Bethea

“We’ve seen increased consumer interest in health and wellness since COVID. They’re more interested in high-protein products, high-fiber products, low-sugar products, convenience,” the executive said. “That’s only been accelerated by the rise of adoption of anti-diabetes and anti-obesity medication. People taking GLP-1 drugs have different nutrition needs, and our portfolio is well positioned to deliver against those [needs].”

To better meet evolving consumer demands, Danone has tested ad campaigns that run on Pinterest and on-site display with diet-focused messaging. The marketer also encouraged the FDA to make its first qualified health claim for yogurt, information that is shared when consumers shop at Target, Amazon or Walmart for Danone yogurt.

Marketing Dive spoke with Bethea about these ad experiments and how the marketer is approaching retail media networks, artificial intelligence (AI) and Super Bowl advertising.

The following interview has been edited for clarity and brevity.

MARKETING DIVE: How does Danone adapt the marketing of its portfolio to meet consumer changes like the increased interest in GLP-1-ready diets?

LINDA BETHEA: Everything comes back to our purpose at Danone. We have a mission to deliver health through food to as many people as possible, so it all starts with making sure that we’re leading with our health-driven portfolio. Seventy percent of our portfolio is nutrient dense and can deliver against these evolving consumer needs. But with such a broad portfolio, we need to make sure that each one of our brands is delivering in a way that makes sense for that brand.

For example, Oikos is the high-protein brand in our yogurt portfolio. Protein consumption is something that’s of utmost interest for consumers: 71% of adults say they’re interested in increasing the amount of protein in their diets, and so we’re leaning into that and increasing our focus on protein-led messaging with Oikos, which led to it growing 40% last year. We know consumers are looking to increase the amount of plant-based products in their diet, so we lean into that with Silk, and we really try to focus on the benefits of plant-powered goodness across our Silk portfolio. [We stay] true to what each brand stands for, but in a way that ladders up to our overarching Danone mission of delivering health through food.